Literature DB >> 16715187

Safety of gadodiamide mixed with a small quantity of iohexol in patients with impaired renal function undergoing coronary angiography.

Cem Barcin1, Hurkan Kursaklioglu, Atilla Iyisoy, Sedat Kose, Hasan Fehmi Tore, Ersoy Isik.   

Abstract

Gadolinium-based contrast agents can be used in diagnostic and interventional angiography, and are safe in recommended doses in patients with impaired renal function, but the image quality is usually unsatisfactory. The objective of the present study is to evaluate the safety of gadolinium mixed with a small quantity of iodine-based contrast agent and the image quality of this mixture in patients with renal insufficiency undergoing diagnostic coronary angiography. Forty-two patients with baseline creatinine level>1.5 mg/dl were randomized into gadolinium or iodine groups. In the gadolinium group gadodiamide was mixed with 1:3 iohexole and in the iodine group only this agent was used as contrast material. Peak creatinine levels 48-72 h after the procedure were measured. The primary end point was the development of contrast-induced nephropathy (CIN), defined as >25% increase of baseline creatinine levels, and the secondary end points were absolute and relative changes in baseline creatinine levels. Total contrast volumes used were not different between groups (57+/-11 ml in gadolinium and 55+/-10 ml in iodine; P=0.68). Mean creatinine level did not increase significantly in the gadolinium group (from 1.9+/-0.3 to 1.9+/-0.4 mg/dl; P=0.06), but did in the iodine group (from 2.0+/-0.4 to 2.3+/-0.5 mg/dl; P=0.001). No patient had CIN in the gadolinium group whereas 5 (23%) patients had this phenomenon in the iodine group (P=0.048). Contrast regimen was very well tolerated in the gadolinium group, with only transient headache in two patients. Gadodiamide mixed with a small quantity of iohexol is safe in patients with azotemia undergoing diagnostic coronary angiography. The image qualities obtained with this combination are also satisfactory in all of the cases. Further evaluation of the safety of this technique is warranted, especially in other types of diagnostic and interventional procedures in which a higher amount of contrast dye is needed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16715187     DOI: 10.1007/s00380-005-0879-8

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  21 in total

1.  Gadolinium-based contrast agents in angiography and interventional radiology.

Authors:  D J Spinosa; A H Matsumoto; K D Hagspiel; J F Angle; G D Hartwell
Journal:  AJR Am J Roentgenol       Date:  1999-11       Impact factor: 3.959

2.  Selective angiography of cerebral aneurysm using gadodiamide in polycystic kidney disease with renal insufficiency.

Authors:  S G Slaba; L F El-Hajj; G A Abboud; V A Gebara
Journal:  AJR Am J Roentgenol       Date:  2000-11       Impact factor: 3.959

3.  Use of a mixture of gadolinium and iodinated contrast for angiography.

Authors:  Carlos M Badiola
Journal:  Cardiovasc Intervent Radiol       Date:  2004 Mar-Apr       Impact factor: 2.740

4.  Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality.

Authors:  P A McCullough; R Wolyn; L L Rocher; R N Levin; W W O'Neill
Journal:  Am J Med       Date:  1997-11       Impact factor: 4.965

5.  Use of gadolinium as an intraarterial contrast agent in digital subtraction angiography of the cervical carotid arteries and intracranial circulation. Technical note.

Authors:  E S Nussbaum; S O Casey; L A Sebring; M T Madison
Journal:  J Neurosurg       Date:  2000-05       Impact factor: 5.115

6.  Innominate artery atheroma: a lesion seen with gadolinium-enhanced MR angiography and often missed by transesophageal echocardiography.

Authors:  G A Krinsky; R Freedberg; V S Lee; C Rockman; P A Tunick
Journal:  Clin Imaging       Date:  2001 Jul-Aug       Impact factor: 1.605

7.  The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency.

Authors:  L Gruberg; G S Mintz; R Mehran; G Gangas; A J Lansky; K M Kent; A D Pichard; L F Satler; M B Leon
Journal:  J Am Coll Cardiol       Date:  2000-11-01       Impact factor: 24.094

8.  Gadolinium-based percutaneous coronary intervention in a patient with renal insufficiency.

Authors:  Syed W Bokhari; Yung-Hsi J Wen; Rex J Winters
Journal:  Catheter Cardiovasc Interv       Date:  2003-03       Impact factor: 2.692

9.  Dosing of contrast material to prevent contrast nephropathy in patients with renal disease.

Authors:  R G Cigarroa; R A Lange; R H Williams; L D Hillis
Journal:  Am J Med       Date:  1989-06       Impact factor: 4.965

10.  Safety of gadolinium contrast angiography in patients with chronic renal insufficiency.

Authors:  Albert D Sam; Mark D Morasch; Jeremy Collins; Gina Song; Richard Chen; F Scott Pereles
Journal:  J Vasc Surg       Date:  2003-08       Impact factor: 4.268

View more
  2 in total

1.  The dogma that gadolinium contrast media are less nephrotoxic than iodine agents for X-ray angiography is a misconception.

Authors:  Ulf Nyman; Barbara Elmståhl; Mats Nilsson
Journal:  Heart Vessels       Date:  2007-05-21       Impact factor: 2.037

2.  Iodine contrast iso-attenuating with diagnostic gadolinium doses in CTA and angiography results in ultra-low iodine doses. A way to avoid both CIN and NSF in azotemic patients?

Authors:  Ulf Nyman; Barbara Elmståhl; Håkan Geijer; Peter Leander; Torsten Almén; Mats Nilsson
Journal:  Eur Radiol       Date:  2010-08-29       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.